969 related articles for article (PubMed ID: 2418117)
1. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
Lynch DH; Daynes RA; Hodes RJ
J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
3. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
4. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
5. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
Lynch DH; Gurish MF; Daynes RA
Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
[TBL] [Abstract][Full Text] [Related]
8. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
9. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
10. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
[TBL] [Abstract][Full Text] [Related]
11. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
12. Immunodominance in the T cell response to multiple non-H-2 histocompatibility antigens. IV. Partial tissue distribution and mapping of immunodominant antigens.
Wettstein PJ; Colombo MP
J Immunol; 1987 Oct; 139(7):2166-71. PubMed ID: 2958540
[TBL] [Abstract][Full Text] [Related]
13. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
[TBL] [Abstract][Full Text] [Related]
14. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
[TBL] [Abstract][Full Text] [Related]
15. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
16. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
Plata F; Jongeneel V; Cerottini JC; Brunner KT
Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
[TBL] [Abstract][Full Text] [Related]
17. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
Lake JP; Kapp JA; Pierce CW
J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
[TBL] [Abstract][Full Text] [Related]
18. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
19. Anti-idiotypic antibodies against UV-induced tumor-specific CTL clones. Preparation in syngeneic combination.
Kuribayashi K; Tanaka C; Matsubayashi Y; Masuda T; Udono H; Abe M; Nakayama E; Shiku H
J Immunol; 1988 Dec; 141(11):4074-80. PubMed ID: 2460558
[TBL] [Abstract][Full Text] [Related]
20. Suppressor T cells, distinct from "veto cells," are induced by alloantigen priming and mediate transferable suppression of cytotoxic T lymphocyte responses in vivo.
Owens T; Crispe IN
J Immunol; 1985 Nov; 135(5):2984-9. PubMed ID: 2413108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]